Emerging RNA Therapy Shows Potential to Boost Memory and Alleviate Anxiety

Cognigenics has developed a new RNA-based therapy, COG-201, showing promise in improving memory and reducing anxiety in animals by targeting the serotonin 5-HT2A receptor. The therapy, administered intranasally, could revolutionize treatment for cognitive impairments and mood disorders. RNA-Based Therapy in Neuroscience Scientists at Cognigenics have made a significant advance in the field of neuroscience and [...]

from SciTechDaily https://ift.tt/OgfPXGm